Susanne Hamann

Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study

Beate Schultheis, Gunnar Folprecht, Jan Kuhlmann et al. · Annals of Oncology · 2013 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study

Sven Schmidt, Susanne Hamann, Jan M. Langrehr et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2007 · 92 citations

Medicine, Perioperative Medicine, Surgery +7

Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

Gunnar Folprecht, Susanne Hamann, Katharina Schütte et al. · BMC Cancer · 2014 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I study of regorafenib sequentially administered with either FOLFOX or FOLFIRI in patients with first-/second-line colorectal cancer.

Beate Schultheis, Gunnar Folprecht, Jan Kuhlmann et al. · Journal of Clinical Oncology · 2011 · 13 citations

Medicine, Oncology, Pharmacology +12